{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:20:56Z","timestamp":1790774456480,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2406,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1124\/jpet.117.247429","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T20:50:17Z","timestamp":1523479817000},"page":"664-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease"],"prefix":"10.1016","volume":"365","author":[{"given":"Jenny V.","family":"Tobin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Germano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie G.","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Ranganath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G-Yoon Jamie","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"James","family":"Sheppeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Banijamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert T.","family":"Profy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Todd","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Masferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.247429_bib1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1073\/pnas.0304264101","article-title":"Anti-inflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment","volume":"101","author":"Ahluwalia","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.117.247429_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/rccm.200801-121OC","article-title":"Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension","volume":"178","author":"Baliga","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1124\/jpet.117.247429_bib3","article-title":"Quantitative tissue distribution and pharmacokinetics of IW-1973, a novel clinical-stage sGC stimulator, after oral administration in rats","volume":"31","author":"Banijamali","year":"2017","journal-title":"Faseb J"},{"key":"10.1124\/jpet.117.247429_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-6175.2002.00503.x","article-title":"Salt intake, endothelial dysfunction, and salt-sensitive hypertension","volume":"4","author":"Bragulat","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1124\/jpet.117.247429_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1006\/bbrc.1999.1444","article-title":"Tissue distribution of the human soluble guanylate cyclases","volume":"263","author":"Budworth","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.117.247429_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s40265-013-0149-5","article-title":"Riociguat: first global approval","volume":"73","author":"Conole","year":"2013","journal-title":"Drugs"},{"key":"10.1124\/jpet.117.247429_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/jpet.117.247429_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.117.247429_bib9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/bph.14137","article-title":"The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitis","volume":"175","author":"Flores-Costa","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.117.247429_bib10","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1002\/anie.201302588","article-title":"The chemistry and biology of soluble guanylate cyclase stimulators and activators","volume":"52","author":"Follmann","year":"2013","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/jpet.117.247429_bib11","doi-asserted-by":"crossref","first-page":"e21853","DOI":"10.1371\/journal.pone.0021853","article-title":"Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats","volume":"6","author":"Geschka","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.247429_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","article-title":"Soluble guanylate cyclase: a potential therapeutic target for heart failure","volume":"18","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1124\/jpet.117.247429_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1165\/rcmb.2014-0092OC","article-title":"Guanylyl cyclase activation reverses resistive breathing-induced lung injury and inflammation","volume":"52","author":"Glynos","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.117.247429_bib14","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/ATVBAHA.111.236554","article-title":"Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding","volume":"31","author":"Handa","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.117.247429_bib15","doi-asserted-by":"crossref","unstructured":"Hanrahan JP, Wakefield J, Wilson P, Mihova M, Chickering JG, Ruff D, Hall M, Milne GT, Currie MG, Profy AT (2017) Multiple-ascending-dose study of IW-1973, a soluble guanylate cyclase stimulator, in Proceeding of the AHA Council on Hypertension, AHA Council on Kidney in Cardiovascular Disease, American Society of Hypertension Joint Scientific Sessions; 2017 September 14\u201317; San Francisco, CA. Hypertension, September 2017","DOI":"10.1161\/hyp.70.suppl_1.p493"},{"key":"10.1124\/jpet.117.247429_bib16","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1038\/ncomms8235","article-title":"Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue","volume":"6","author":"Hoffmann","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.117.247429_bib17","doi-asserted-by":"crossref","first-page":"e0145048","DOI":"10.1371\/journal.pone.0145048","article-title":"Chronic activation of heme free guanylate cyclase leads to renal protection in Dahl salt-sensitive rats","volume":"10","author":"Hoffmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.247429_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1358\/dot.2006.42.12.1032057","article-title":"Sildenafil citrate for the treatment of pulmonary hypertension","volume":"42","author":"Hrometz","year":"2006","journal-title":"Drugs Today (Barc)"},{"key":"10.1124\/jpet.117.247429_bib28","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V84.12.4226.bloodjournal84124226","article-title":"YC-1, a novel activator of platelet guanylate cyclase","volume":"84","author":"Ko","year":"1994","journal-title":"Blood"},{"key":"10.1124\/jpet.117.247429_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/3-540-32967-6_7","article-title":"Nitric oxide and the vascular endothelium","volume":"176","author":"Moncada","year":"2006","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.117.247429_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/07853890701854702","article-title":"Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction","volume":"40","author":"M\u00fcnzel","year":"2008","journal-title":"Ann Med"},{"key":"10.1124\/jpet.117.247429_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(02)46032-1","article-title":"Nitroglycerin as a remedy for angina pectoris","volume":"1","author":"Murrell","year":"1879","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1124\/jpet.117.247429_bib22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2016.08.022","article-title":"Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence","volume":"122","author":"Sandner","year":"2017","journal-title":"Respir Med"},{"key":"10.1124\/jpet.117.247429_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1096\/fasebj.29.1_supplement.623.9","article-title":"sGC stimulator efficacy: beyond blood pressure in Dahl-salt sensitive model of hypertension","volume":"29","author":"Shea","year":"2015","journal-title":"Faseb J"},{"key":"10.1124\/jpet.117.247429_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0704484","article-title":"Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies","volume":"135","author":"Stasch","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.117.247429_bib25","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1124\/jpet.117.247429_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2014.12.014","article-title":"Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence","volume":"21","author":"Stasch","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/jpet.117.247429_bib27","unstructured":"Zimmer DP, Tobin J, Shea C, Sarno R, Long K, Jacobson S, Tang K, Germano P, Wakefield J, Im GY, et al. (2017) Cardiovascular actions and tissue distribution of IW-1973 \u2013 a clinical-stage soluble guanylate cyclase stimulator, in Proceeding of the 8th International Conference on cGMP; 2017 June 23; Bamberg, Germany Biomed Central."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.247429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:04:27Z","timestamp":1739995467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524267823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0022356524267823"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.247429","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.247429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}